Vivakor Extends Its Business Development Agreement With Baker Consulting
Related Quotes
| Symbol |
Price |
Change |
| VIVK.OB |
0.03 |
-0.01 |
|
|
{”s” : “vivk.ob”,”k” : “a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00″,”o” : “”,”j” : “”}
Press Release Source: Vivakor, Inc. On Monday June 7, 2010, 6:14 pm EDT
CORALVILLE, Iowa, June 7, 2010 (GLOBE NEWSWIRE) — Vivakor, Inc. (OTCBB:VIVK – News) has extended its Business Development agreement with Baker Consulting out of Walnut Creek, California and its affiliate group, Kyouko Group, Inc. out of South Florida for an additional six months. Baker Consulting has made great strides in assisting the company with distribution agreements and research collaboration. Vivakor's Chairman Matt Nicosia stated recently, “Baker Consulting, with its vast experience in medical device commercialization and corporate finance, has been very instrumental in our Company's commercialization efforts and we are very pleased in the progress that has been made thus far and we look forward to creating great value for Vivakor shareholders through this relationship.”
About Vivakor, Inc.
Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handing and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at http://www.vivakor.com/.
Forums
